The novel therapy of the medication represents a major development in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide363538.blogoxo.com/42409065/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment